GLP1R and type 2 diabetes mellitus: Recently, Kuo et al. [96] performed two retrospective cohort studies to compare the utility of GLP-1 RAs versus dipeptidyl peptidase-4 inhibitors (DPP-4is) in patients with T2DM.